Loss of FMR1 gene function results in fragile X syndrome, the most common heritable form of intellectual disability. The protein encoded by this locus (FMRP) is an RNA-binding protein that is thought to primarily act as a translational regulator; however, recent studies have implicated FMRP in other mechanisms of gene regulation. We found that the Drosophila fragile X homolog (dFMR1) biochemically interacted with the adenosine-to-inosine RNA-editing enzyme dADAR. Adar and Fmr1 mutant larvae exhibited distinct morphological neuromuscular junction (NMJ) defects. Epistasis experiments based on these phenotypic differences revealed that Adar acts downstream of Fmr1 and that dFMR1 modulates dADAR activity. Furthermore, sequence analyses revealed that a loss or overexpression of dFMR1 affects editing efficiency on certain dADAR targets with defined roles in synaptic transmission. These results link dFMR1 with the RNA-editing pathway and suggest that proper NMJ synaptic architecture requires modulation of dADAR activity by dFMR1.
a r t I C l e S Fragile X syndrome (FXS) is the most common heritable form of intellectual impairment and is a known genetic cause of autism. Individuals with this disease exhibit learning disabilities and an array of behavioral and cognitive deficits, in addition to abnormal synaptic development and function 1 . The most prevalent genetic aberration associated with FXS arises from a CGG repeat in the 5′ untranslated region of the fragile X mental retardation 1 gene (FMR1). Expansion of this region results in hypermethylation and subsequent transcriptional silencing of the FMR1 gene, preventing expression of the FMRP protein 1 .
Previous studies have suggested that translational regulation by FMRP is essential for aspects of neuronal function and synaptic development. FMRP is an RNA-binding protein that co-sediments with ribonucleoprotein (RNP) particles and translating polyribosomes [2] [3] [4] [5] . In vitro and in vivo analyses suggest that FMRP functions as a translational repressor 6, 7 ; however, recent studies have shown that FMRP can also positively regulate expression of certain target mRNAs 8, 9 . Moreover, FMRP is present at synapses, where localized protein translation occurs, and is rapidly translated on metabotropic glutamate receptor (mGluR) stimulation 10 . Thus, it has been proposed that FMRP regulates synaptically localized protein translation and subsequently affects synaptic plasticity. How misregulation of this process leads to the synaptic and cognitive defects observed in FXS, however, remains unclear.
Although the role for FMRP in translational regulation has been well studied, recent findings suggest that FMRP also affects other aspects of post-transcriptional gene regulation. FMRP regulates stability of certain transcripts, such as DLG-4 (PSD-95) 11 , and also regulates activity-dependent mRNA transport and localization in neurons [12] [13] [14] . In addition, FMRP interacts with multiple pathways that regulate gene expression, including the RNA interference pathway [15] [16] [17] [18] [19] [20] . Collectively, these findings suggest multiple roles for FMRP in post-transcriptional gene regulation.
We found that dFMR1 acts in the RNA editing system mediated by Drosophila adenosine deaminase acting on RNA (dADAR). Using a tandem affinity purification (TAP) screen, we identified dADAR as a protein that associates with dFMR1. ADARs act to catalytically deaminate adenosine residues to inosine residues in doublestrand RNA templates 21 . Because inosine is interpreted as guanosine by the translational machinery, adenosine-to-inosine (A-to-I) editing in coding mRNAs may lead to the incorporation of amino acids that are not directly encoded by the genomic template 21 . Proper ADAR function is critical for neuronal integrity, as loss-of-function mutations in several model organisms result in severe neurological defects or lethality [22] [23] [24] , and mRNAs edited by ADARs are enriched for those encoding ion channels and genes that are important for synaptic transmission and architecture 25 .
To determine whether Fmr1 and Adar genetically interact, we took advantage of the NMJ system, where dFMR1 has previously been shown to function 26 . We found that dADAR expression and function was essential for normal NMJ morphology and that Adar acted downstream of Fmr1 for proper NMJ synaptic architecture. Sequence analyses of dADAR substrates revealed that dFMR1 affected the editing efficiency of particular transcripts involved in synaptic transmission. These findings suggest a mechanism by which FMRP affects gene regulation and function through its association with dADARdependent RNA editing. a r t I C l e S RESULTS dFMR1 biochemically interacts with dADAR To explore the biochemical function of dFMR1, we used a combined strategy of TAP followed by mass spectrometry analysis to identify interacting proteins 27 . We generated S2 cell lines that expressed a recombinant form of the dFMR1 protein with a carboxy-terminal (C-terminal) TAP tag (dFMR1-cTAP) ( Supplementary Fig. 1 ). Extracts from S2 cells expressing dFMR1-cTAP or cTAP alone were used for the TAP pulldown, and eluates were subjected to SDS-PAGE electrophoresis ( Supplementary Fig. 1 ).
One protein that was identified in the dFMR1-cTAP-expressing eluates was dADAR, the A-to-I RNA-editing enzyme. To verify the interaction between dFMR1 and dADAR, we transfected S2 cells with constructs that expressed two differentially spliced dADAR isoforms with a modified TAP tag 28, 29 (Fig. 1a,b) . Using a modified TAP method with dADAR-TAP-expressing lysates, we found that dFMR1 co-purified with both isoforms of dADAR-TAP, but not with control samples (Fig. 1c) , indicating that dFMR1 and dADAR associate in S2 cells.
To determine whether this interaction is dependent on RNA, we carried out the TAP pulldown in the presence of RNase A. dFMR1 reproducibly co-purified with dADAR-TAP in samples treated with RNase A, but to a lesser degree than in untreated samples ( Fig. 1c) . Reverse-transcription PCR (RT-PCR) amplification and ethidium bromide staining of total RNA isolated from extracts used for the pulldown confirmed the efficient removal of RNA from the RNasetreated samples (Fig. 1d ). Because the interaction was not ablated by RNase A treatment, these results suggest that the association between dADAR and dFMR1 is possibly enhanced by the presence of RNA.
It is also possible that a subset of dFMR1 pulled down in our TAP purification represents a pool that does not interact with dADAR, but is instead simply tethered to RNAs that are also bound by dADAR.
To confirm that dFMR1 and dADAR interact in vivo, we performed co-immunoprecipitation experiments using two independent fly lines that contain an HA tag inserted in the endogenous Adar open reading frame (Adar-HA 4.5.2 and Adar-HA 12.5.2 ) 30 . Co-immunoprecipitation experiments using adult head lysates revealed that dFMR1 associates with dADAR-HA in the two independent Adar-HA lines, but not in control samples ( Fig. 1e) , demonstrating an interaction between dADAR and dFMR1 in vivo.
We next sought to determine where dFMR1 and dADAR associate in the cell, as both proteins exhibit different localization patterns at the subcellular level. dADAR primarily resides in the nucleus, where A-to-I deamination normally occurs, whereas FMRP is mostly observed in the cytoplasm, despite containing nuclear localization and export signals 31, 32 . Because treatment of COS cells with leptomycin B (LMB), an inhibitor of exportin 1-dependent nuclear export, is able to trap FMRP in the nucleus 33 , we assessed dFMR1 and dADAR subcellular localization in S2 cells treated with LMB to increase the amount of dFMR1 in the nucleus (Supplementary Fig. 2 ). As previously shown 30, 33 , we observed nuclear-specific localization of dADAR in S2 cells expressing dADAR-TAP recombinant protein, as well as an increase in the amount of dFMR1 in the nucleus by approximately 2.4-fold relative to vehicle control-treated cells, verifying that dFMR1 and dADAR are both expressed in the nucleus (Supplementary Fig. 2 ). Furthermore, TAP pulldowns using dADAR-TAP-expressing S2 cells treated with LMB increased the amount of dFMR1 pulled down with dADAR-TAP by at least 2-fold compared with control samples 
a r t I C l e S ( Supplementary Fig. 2 ). On the basis of these results, we predict that dFMR1 and dADAR associate in the nucleus.
Adar mutant larvae exhibit morphological NMJ defects
To explore the physiological importance of the dFMR1-dADAR biochemical interaction, we used the NMJ system in third instar larvae. Previous studies found that loss and overexpression of dFMR1 give rise to opposing defects in NMJ synaptic architecture 15, 26 . Although NMJ defects in Adar mutants have never been identified, loss of ADAR expression leads to severe behavioral and neuronal defects in Drosophila and other model systems [22] [23] [24] . Furthermore, many characterized dADAR substrates encode for proteins that function in synaptic transmission at the NMJ 34 . Analyses of Adar 5G1 null larvae 22 revealed morphological NMJ defects in two different muscles analyzed ( Fig. 2a,b) . Adar 5G1 mutant larvae exhibited a 59% and 35% increase in the total number of type 1 synaptic boutons compared with wild-type samples in muscles 6/7 ( Fig. 2c ) and muscle 4 ( Fig. 2d) , respectively. Quantification of branching in muscles 6/7 also revealed that Adar 5G1 mutants exhibited an increase in branching compared with control samples (6.2 ± 0.2 in Adar 5G1 compared with 3.5 ± 0.2 in wild type, n ≥ 16, P < 0.001). To further examine the Adar 5G1 mutant phenotype, we next quantified the two subclasses of type 1 synaptic boutons (type 1s and type 1b), which exhibit different electrophysiological properties 35 . We found that the increase in type 1 synaptic boutons in Adar 5G1 mutants arose largely from an increase in type 1s synaptic boutons, whereas type 1b synaptic boutons were subtly affected, if at all, when compared with control genotypes (Fig. 2c,d) . From these data, we conclude that a loss of dADAR expression leads to defects in NMJ synaptic architecture.
To validate the Adar 5G1 mutant phenotype and to determine where dADAR is required for normal NMJ synaptic architecture, we used the Gal4/UAS system to express dADAR in tissue-specific regions ( Fig. 3a) . To verify that the NMJ defects observed in Adar 5G1 mutant larvae are the result of an absence of dADAR expression and not of genetic background effects, we expressed dADAR ubiquitously from a wild-type UAS-Adar transgene using a β-tubulin-Gal4 (βTub-Gal4) driver, which expressed dADAR at higher levels than the endogenous Adar promoter ( Fig. 3b) . Ubiquitous expression of dADAR completely rescued the NMJ phenotype observed in Adar 5G1 larvae with respect to synaptic bouton number and branching (Fig. 3c,d and Supplementary Table 1 ), supporting our finding that dADAR expression is required for aspects of NMJ morphology.
We next determined whether pre-or postsynaptic expression of dADAR was sufficient to rescue the morphological phenotypes observed in Adar 5G1 mutant larvae. We found that neuronal expression of dADAR using the elav-Gal4 and scratch-Gal4 drivers rescued the NMJ defects observed in Adar 5G1 mutants (Fig. 3c,d and Supplementary Table 1 ). In contrast, postsynaptic expression of dADAR in muscle using either the myosin heavy chain-Gal4 (MHC-Gal4) or G14-Gal4 drivers failed to rescue the Adar 5G1 NMJ phenotype ( Fig. 3c,d and Supplementary Table 1 ). Thus, we conclude that neuronal expression of dADAR is sufficient for proper NMJ synaptic architecture. These findings are consistent with published reports with respect to the spatial requirements of dFMR1 for proper NMJ morphology 36 .
To determine whether normal NMJ synaptic architecture is dependent on the A-to-I RNA-editing function of dADAR, we took advantage of an active site glutamate-to-alanine substitution in motif I of the catalytic deaminase domain (Adar(EA)) that severely reduces catalytic activity 37 . Ubiquitous expression of the UAS-Adar(EA) transgene in an Adar mutant background results in minimal rescue in locomotor activity and substantially reduced levels of editing 37 , but can still compete with wild-type dADAR isoforms for RNA substrates 38 . We crossed the UAS-Adar(EA) transgene into the Adar 5G1 null background to determine whether the catalytically inactive dADAR(EA) protein would rescue the Adar 5G1 NMJ defects. We found that the Adar(EA) transgene, driven by a βTub-Gal4 driver, was unable to rescue the NMJ defects observed in Adar 5G1 mutant larvae ( Fig. 4a-c) , despite being expressed at higher levels than endogenous dADAR ( Fig. 4d) . These results indicate that functional deaminase activity of dADAR is required for normal NMJ synaptic architecture.
Adar is epistatic to Fmr1 with respect to NMJ morphology Given that our results indicated that dADAR expression and catalytic activity are required for normal NMJ synaptic architecture, and previous studies reported NMJ defects in Fmr1 mutants 15, 26 , we directly compared the Fmr1 and Adar 5G1 mutant phenotypes. Quantitative analyses using Adar 5G1 and Fmr1 3 mutant animals revealed that a loss of either dADAR or dFMR1 expression resulted in a similar increase in the number of type I synaptic boutons (Adar 5G1 , 66.6 ± 1.9; Fmr1 3 , 63.3 ± 2.3, wild type, 40.8 ± 2.3; n ≥ 16, P < 0.001) and branching (Adar 5G1 , 6.2 ± 0.2; Fmr1 3 , 6.0 ± 0.2; wild type, 3.5 ± 0.2; n ≥ 16, P < 0.001) a r t I C l e S compared to wild-type controls. However, morphological analyses indicated that the phenotypes observed in the single mutants are distinct from each other ( Fig. 5a) . To examine the phenotypic difference in more detail, we quantified the morphological synaptic defects into two categories: subclasses of type 1 synaptic boutons and primary branch length. Although Adar mutants exhibited a greater increase in type 1s synaptic boutons than type 1b boutons in L3 larvae compared with controls, loss of dFMR1 expression led to similar increases in both type 1b and type 1s synaptic boutons compared to wild-type samples (Fig. 5b) . In addition, previous reports 26 and our analyses revealed that Fmr1 3 mutant larvae exhibited an increase in the length of the primary nerve branch when compared with control samples, whereas the primary branch length in Adar 5G1 mutants was largely unaffected in comparison to control larvae ( Fig. 5c) . We therefore conclude that, although both dADAR and dFMR1 affect NMJ synaptic architecture, the single mutant phenotypes are distinct from one another. We used the distinct NMJ phenotypes in Fmr1 and Adar mutants to perform genetic epistasis experiments. Comparison of the Adar 5G1 ; Fmr1 3 double mutant larvae to the Adar 5G1 and Fmr1 3 single mutants revealed that the Adar 5G1 ; Fmr1 3 double null larvae exhibited an Adar 5G1 single mutant-like phenotype with respect to the subclasses of type 1 synaptic boutons ( Fig. 5b ) and primary branch length ( Fig. 5c ). Overexpression of dFMR1 leads to NMJ morphological defects that are characterized by a reduction in the number of synaptic boutons, branching and primary branch length compared Figure 3 Neuronal expression of dADAR is sufficient for normal NMJ synaptic architecture. (a) Confocal images of the NMJ from the following genotypes: wild type, Adar 5G1 larvae carrying a wild-type UAS-Adar transgene (Adar 5G1 ;UAS-Adar), Adar 5G1 ; UAS-Adar;βTub-Gal4 (ubiquitous expression), Adar 5G1 ;UAS-Adar;elav-Gal4 (neuronal expression), Adar 5G1 ;UAS-Adar;scratch-Gal4 (neuronal expression), Adar 5G1 ; UAS-dAdar; MHC-Gal4 (muscle expression) and Adar 5G1 ;UAS-Adar; G14-Gal4 (muscle expression). Larvae were stained for CSP (presynaptic, magenta) and DLG (postsynaptic, green). No noticeable differences in CSP and DLG intensity were observed across genotypes. Scale bar represents 50 µm. (1), Adar-HA 12.5.2 (2), Adar 5G1 ;UAS-Adar(EA) (3) and Adar 5G1 ;UAS-Adar(EA);βTub-Gal4 (4) L3 larval brains. As observed with the wild-type Adar transgene (see Fig. 3b ), Adar(EA) expression was higher compared with endogenous dADAR levels. β-Tubulin served as a loading control. 15, 26 . Quantitative analyses of Adar 5G1 ; Fmr1(4X) larvae revealed that the loss of dADAR activity in Fmr1(4X) overexpression mutants also resulted in an Adar 5G1 null phenotype with respect to type 1s and type 1b synaptic boutons (Fig. 5b) , primary branch length ( Fig. 5c ) and the number of synaptic branches (data not shown). Thus, neither loss nor overexpression of dFMR1 had any effect on NMJ morphology in the absence of dADAR expression. From these results, we conclude that Fmr1 and Adar genetically interact and that Adar is epistatic to Fmr1 with respect to NMJ synaptic architecture. Given that we observed a physical interaction between dFMR1 and dADAR, we propose that Fmr1 and Adar are in a similar pathway with respect to NMJ synaptic development and that Adar functions downstream of Fmr1.
To better characterize the genetic interaction between Adar and Fmr1 at the NMJ, we examined NMJ architecture in trans heterozygous genotypes. We reduced Adar dosage in a Fmr1 loss-of-function or gain-of-function background and quantified the number of type 1s and type 1b synaptic boutons in various Adar; Fmr1 combinatorial genotypes. Notably, reduction of Adar dosage in a Fmr1 3 mutant background genetically suppressed the Fmr1 3 null NMJ phenotype to wild type with respect to the number of type 1 synaptic boutons (Fig. 6) . We also reduced Adar dosage in Fmr1(4X) overexpressing flies, but saw neither rescue nor enhancement of the Fmr1(4X) phenotype (Supplementary Fig. 3) . These results further support the model that Adar is downstream of Fmr1 with respect to NMJ synaptic architecture. Because the Fmr1 3 NMJ phenotype was rescued by reducing Adar dosage, we predict that loss of dFMR1 expression leads to aberrant dADAR activity, which can be prevented by reducing Adar dosage. dFMR1 modulates dADAR-dependent RNA-editing activity Our genetic analyses suggest that dFMR1 modulates dADAR function with respect to NMJ development. Thus, we next explored how dFMR1 acts on dADAR activity to regulate NMJ architecture. Because dFMR1 can act as a translational regulator, we first examined dADAR expression and localization in Fmr1 mutant backgrounds. Western and immunohistochemistry analyses failed to reveal a detectable change in both dADAR-HA expression and localization in Fmr1 lossof-function and gain-of-function backgrounds compared to wild type (Supplementary Fig. 4) . Similarly, Western analyses on all genotypes used for the epistasis experiments revealed that dFMR1 was expressed at expected levels for all genotypes (Supplementary Fig. 5) , indicating that the genetic interaction between dFMR1 and dADAR is not a result of alterations in expression levels of the two proteins. Figure 5 Adar and Fmr1 genetically interact. (a) Confocal images of L3 larval NMJs from the following genotypes: wild type, Adar 5G1 , Fmr1 3 , Fmr1(4X), Adar 5G1 ;Fmr1 3 and Adar 5G1 ;Fmr1(4X). L3 larvae were stained for CSP (presynaptic, magenta) and DLG (postsynaptic, green). Type 1b and type 1s synaptic boutons were distinguished as described in Figure 2 . No noticeable differences in CSP and DLG intensity were observed across genotypes. Scale bar represents 50 µm. (b) Genetic studies demonstrating that Adar is epistatic to Fmr1 with respect to synaptic bouton formation. Quantification of average number of type 1b (black bars) and type 1s (white bars) synaptic boutons for genotypes shown in a. (c) Genetic studies demonstrating that Adar is epistatic to Fmr1 with respect to primary branch length. Relative primary branch length was quantified for all genotypes shown in a using HRP staining. The length of the primary branch length was normalized to the length of the abdominal hemisegment, and mean relative primary branch length was measured and plotted for each genotype. All images and quantification were performed using muscles 6/7, hemisegment A3 (n ≥ 16 for each genotype). Error bars denote s.e.m. *P < 0.05, **P < 0.01, ***P < 0.001, analyzed by one-way ANOVA, P < 0.0001 overall, Tukey-Kramer post-test. 
a r t I C l e S
To determine whether dADAR's editing function is influenced by dFMR1, we examined the editing efficiency of known dADAR substrates in Fmr1 mutant backgrounds. We found that altering dFMR1 expression led to differential effects on editing efficiency in five of the six transcripts that we analyzed: lap, Caα1D, shab, stnB and syt1 (Fig. 7a) . Notably, editing levels at two of the transcripts that we analyzed (lap and Caα1D) exhibited a clear bi-directional change in response to reduced or increased dFMR1 expression ( Fig. 7a,b) . Editing patterns at other sites showed nonlinear changes in response to changes in dFMR1 expression levels. For example, editing levels of sites 3 and 5 of the shab potassium channel were substantially higher in controls compared to Fmr1 3 null and Fmr1(4X) overexpressing larvae (Fig. 7a) .
We next ascertained whether dFMR1 associates with transcripts that are edited by dADAR using RNA immunoprecipitation followed by quantitative RT-PCR. As a positive control, we first demonstrated that dADAR-HA associated with the six edited transcripts used for the sequencing analysis (Fig. 7c) . We observed an approximate 2.8-13.5-fold enrichment of edited transcripts in the Adar-HA 12.5.2immunoprecipitated complexes compared with control samples, but found no enrichment of a control unedited transcript TBP (Fig. 7c) . We further found that Caα1D, lap, stnB, shab, unc-13 and syt1 were all enriched in the dFMR1-immunoprecipitated complexes in Fmr1(4X) head extracts compared with dFMR1-deficient extracts by between 1.6-8.2-fold ( Fig. 7c) , indicating that dFMR1 and dADAR-HA associate with similar transcripts in vivo.
Because we found that the presence of RNA enhanced the biochemical association between dFMR1 and dADAR, we next sought to determine whether dFMR1's ability to bind RNA affects its ability to associate with dADAR as well as modulate dADAR's editing activity. We crossed transgenic flies containing point mutations in the RNA-binding KH domains of dFMR1 (Fmr1 I244N and Fmr1 I307N a r t I C l e S to Adar-HA 12.5.2 ; Fmr1 3 flies and performed co-immunoprecipitation experiments to first determine whether a reduction in RNA binding affects dFMR1's ability to associate with dADAR. We found that a point mutation in the KH1 domain (I244N) reduced the abundance of dFMR1 pulled down with dADAR-HA by approximately 60% compared with control samples expressing a wild-type dFMR1 genomic construct (Fig. 7d) . Similar assays were performed with the I307N mutation, but our findings were inconclusive as a result of instability of the mutant dFMR1 protein during the pulldown procedure (data not shown). This finding is consistent with our RNase A experiments and indicates that RNA binding by dFMR1 enhances the dFMR1-dADAR interaction. We next assessed the editing efficiency in the Fmr1 mutant strains to determine whether a reduction in RNA binding by dFMR1 affects dADAR's function. We sequenced lap and Caα1D, as both transcripts exhibited bidirectional effects on editing in the Fmr1 loss-of-function and gain-of-function backgrounds (Fig. 7a) . We predicted that a decrease in RNA binding by dFMR1 would mimic the Fmr1 3 null phenotype, where we observed a decrease in editing in lap and Caα1D compared with control samples (Fig. 7a) . Indeed, we found that both the Fmr1 I244N and Fmr1 I307N mutations in the dFMR1 KH domains decreased the percentage of editing in the lap transcript (Fig. 7e) . In contrast, each point mutation in the dFMR1 KH domains increased editing at sites 2 and 5 of Caα1D (Fig. 7e ), suggesting that mutations in the dFMR1 KH motifs lead to differential effects on editing at particular transcripts. Collectively, these data suggest that dFMR1 is able to associate with dADAR substrates and modify dADAR activity by affecting the editing efficiency of a subset of edited transcripts.
DISCUSSION
Our genetic and molecular findings lead us to propose that modulation of dADAR activity by dFMR1 is important for NMJ synaptic architecture. The epistatic relationship of these two genes, the requirement of RNA editing by dADAR for normal NMJ morphology, and the genetic suppression of the Fmr1 loss-of-function NMJ defects all support a model in which dFMR1 affects the editing activity of dADAR. Molecular analyses of dADAR substrates support this prediction, as we found that both loss and overexpression of dFMR1 result in changes in editing efficiency in several dADAR-dependent editing sites. Although the changes in editing observed in Fmr1 mutant whole larvae were not large (for example, a ~15% change in editing was observed for lap), they are statistically significant (see Fig. 7a,e) , and we propose that these changes would likely be larger if analyses could be performed using mRNA prepared from isolated neurons or synapses rather than whole larvae. In addition, despite a few transcripts that were highly edited throughout development, dADAR function during developmental stages is relatively low compared with its high editing activity in pupal and adult stages 29 . Thus, we cannot rule out a larger effect of dFMR1 levels on dADAR substrates with lower efficiency editing sites.
In considering how dFMR1 affects editing, an important clue might come from the fact that both dFMR1 and dADAR are RNA-binding proteins that associate with secondary and higher order RNA structures. FMRP can bind to two separate complex RNA structures that are believed to allow for specificity of FMRP-associated transcripts: the RGG domain in the C terminus of FMRP protein interacts with an intramolecular G quartet stem loop RNA structure, whereas the KH2 domain associates with a complex tertiary kissing complex RNA structure 40, 41 . Similarly, the dADAR family of proteins contains several double-stranded RNA-binding domains and requires duplex RNA structures to identify, bind to and function on its target RNAs 21 .
The RNA structure required for dADAR activity, however, can vary from a simple hairpin to complex pseudoknot structures.
In addition, our immunoprecipitation experiments indicate that dFMR1 and dADAR associate on common RNA targets. The dADAR-dFMR1 biochemical interaction was reduced through both a decrease in the amount of RNA in our lysates using RNase A as well as by mutating the KH domains of dFMR1, suggesting that the ability for dFMR1 to bind to RNA is important for its association with dADAR. Molecular analyses of lap and Caα1D in the dFMR1 RNA-binding mutants further support this theory, although differential effects were observed with respect to the two transcripts analyzed. It is possible that dFMR1 associates with these two particular transcripts via different RNA-binding motifs. Although the analogous I307N mutation in mammals reduces FMRP's ability to associate with both poly(U)-rich sequences and large RNP complexes 42, 43 , FMRP can still bind to RNA, including transcripts containing G-quartet structures, through an intact RGG RNA-binding motif 42 . Thus, we propose that the I244N and I307N mutations in dFMR1 reduce particular dFMR1-dADAR complexes associating with certain edited transcripts while concurrently enriching for dFMR1-dADAR complexes associating with the dFMR1 RGG box. Further studies delving into the importance of each RNA-binding domain in both dFMR1 and dADAR will give more insight into the biochemical and functional interaction between these two proteins.
On the basis of our results, we predict that dFMR1 and dADAR can associate in a common complex and converge on similar RNA substrates. Because the effect that dFMR1 has on the editing efficiency is context dependent, we propose that the association of dFMR1 with dADAR has no net positive or negative effect on the editing activity of dADAR, but instead maintains a balance of dADAR activity. At sites that demonstrate enhanced editing in the presence of dFMR1, dFMR1 could promote editing by either recruiting dADAR to the site via its own RNA-binding activity, or it could help form and/or stabilize RNA structures that create a site for editing by dADAR. At sites that are negatively affected by the presence of dFMR1, we propose that the RNA binding activity of dFMR1 interferes with the formation of a substrate for dADAR ( Supplementary Fig. 6 ).
Our analyses revealed several transcripts whose level of editing is regulated by the interaction between dFMR1 and dADAR; however, at this time, we do not know how many such transcripts are important for the proper formation of the NMJ. Although many identified dADAR targets encode for proteins that function in synaptic transmission at the NMJ 34 and mutations in several dADAR substrates (for example, syt1, lap and unc-13) affect NMJ synaptic architecture and/or function [44] [45] [46] , how editing is affecting the function of most of these gene products remains unknown. It is also important to note that a role for dFMR1 in translational regulation is already proposed to be important for proper NMJ development through its genetic interaction with the microtubleassociated protein homolog futsch 26 . Collectively, these studies suggest that both dADAR and dFMR1 have multifaceted roles at the NMJ.
In summary, we found that dFMR1 physically and genetically interacts with dADAR-dependent RNA editing. To the best of our knowledge, this is the first report of a disease-associated protein that associates with and modulates A-to-I RNA editing. In addition, our findings reveal a previously unknown function for FMRP with respect to neuronal architecture and expand FMRP's predicted role as a translational regulator. Understanding all of the mechanisms by which FMRP functions to regulate synaptic development and function is essential to better understand the pathogenesis of the FXS symptoms, and consequently can lead to effective therapeutic treatments for people afflicted with this disease. a r t I C l e S METhODS Methods and any associated references are available in the online version of the paper at http://www.nature.com/natureneuroscience/.
Note: Supplementary information is available on the Nature Neuroscience website.
RT-PCR was performed with the Mx 3000 system (Agilent Technologies) using Brilliant III SYBR Green QPCR master mix (Agilent Technologies). For quantitative analysis, the Ct values obtained from the Mx 3000 software were normalized to the input cDNA and control genotypes. Data is represented as the fold difference above control genotypes relative to input cDNA using the following equation: . Fold change of experimental samples relative to control genotypes was then normalized to fold change observed for actin RNA. Statistical analysis was performed using Student's t test using InStat (GraphPad Software). Immunoprecipitation experiments were performed four times and three technical replicates were used for QPCR assays.
RnA editing analysis and statistical analysis. RNA extractions from wild-type, Fmr1 3 and Fmr1(4X) L3 larvae were performed using TRIzol reagent (Invitrogen) using manufacturer's protocol. Analysis of editing efficiency was previously described 30 . Statistical analysis measuring percentage of editing was performed using a Mann-Whitney U test (InStat).
RnA purification and RT-PcR. Total RNA was extracted from ~1.5 µg of S2 cell extract (for RNase A experiments) or from RNA immunoprecipitation samples using TRI Reagent (Ambion) using manufacturer's protocol with the following modifications. After addition of isopropanol and the incubation step, the sample was further purified using columns from RNeasy Mini Kit (Qiagen) with on-column treatment with DNase I (Qiagen) for 20 min at 20-22 °C. cDNA was generated using random hexamers and Superscript III (Qiagen). western analysis. For larval brain and head Western analysis, 2-4 L3 larval brains or 5-10 adult fly heads were dissected in saline buffer or 1× Robbs buffer (55 mM sodium acetate, 40 mM potassium acetate, 100 mM sucrose, 10 mM glucose, 1.2 mM MgCl 2 , 1 mM CaCl 2 , 100 mM HEPES (pH 7.5)), respectively. Lysate preparation, SDS-PAGE, Western analysis and quantification were performed as previously described 15 .
microscopy and statistical analysis. For quantification of synaptic boutons, analysis of muscles 6/7 or muscle 4 in abdominal segment A3 was performed. Confocal images were collected on a Leica TCS SP confocal microscope and represent maximal projections from serial sections spanning the entire NMJ. At least 16 hemisegments were quantified for each genotype per experiment. For Figure 2 , the mean number of synaptic boutons and branching for wild-type and Adar 5G1 mutant samples were analyzed with Student's t test using InStat (GraphPad Software). The mean number of synaptic boutons and branching were analyzed with one-way ANOVA followed by a Tukey-Kramer multiple comparisons post-test using InStat for Figures 3-6. For Figure 5 , primary branch length was normalized to the length of muscles 6/7 for each hemisegment and analyzed by one-way ANOVA followed by a Tukey-Kramer multiple comparisons post-test using InStat. lmB experiments. S2 cells stably expressing dADAR-TAP constructs were induced with CuSO 4 (final concentration of 0.5 mM) overnight (~16-20 h). The next day, cells were treated with either LMB (final concentration 30 nM) or methanol (vehicle control) for 4 h at 20-22 °C. For immunofluorescence analysis, cells were fixed for 10 min in 2% paraformaldehyde, washed three times in 1× PBS, permeabilized in 1× PBT-X (0.1% Triton X-100) for 2 min and incubated with blocker solution (3% BSA, 1% PVP-10, 1% PVP-40, 0.1% PVP-360, all wt/vol) for 10 min at 20-22 °C. Cells were incubated with primary antibody (1:100 mouse antibody to dFMR1 and 1:500 chicken antibody to protein A diluted in 1× PBS) overnight at 4 °C. The following day, cells were washed twice in blocker solution, once in 1× PBS and incubated with secondary antibody (at a final concentration of 1:200) for 30 min at 20-22 °C. Cells were treated with 1 µM TO-PRO-3 (Invitrogen) for 10 min at 20-22 °C, followed by three washes in blocker solution. Following final washes, cells were mounted in Vectashield. Confocal images were collected on a Leica TCS SP confocal microscope using sequential scans. Laser intensity, gain and offset were kept constant for dFMR1 imaging for all samples. Pixel intensity of nuclear dFMR1 staining was quantified using ImageJ and statistical analysis was performed using InStat (Mann-Whitney test). For TAP experiments, cells were harvested after 4 h LMB or vehicle control treatment and TAP was performed as described above.
